
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Jiangsu Alphamab Biopharmaceuticals Co., Ltd)"
Count: 23
Selected: 0
NCT ID | Title |
---|
NCT04601610 | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma | ||
NCT05309512 | Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors | ||
NCT05149326 | KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. | ||
NCT05001724 | KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent | ||
NCT04881929 | Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer | ||
NCT04778982 | Study of KN026 in Combination With Palbociclib With or Without Fulvestrant in Patients With Advanced HER2-positive Breast Cancer | ||
NCT04521179 | Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors | ||
NCT04474119 | KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer | ||
NCT04469725 | KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma | ||
NCT04165993 | Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer | ||
NCT04054531 | Study of KN046 With Chemotherapy in First Line Advanced NSCLC | ||
NCT04038970 | Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate | ||
NCT03925974 | KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer | ||
NCT03925870 | KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma | ||
NCT03872791 | A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer | ||
NCT03847168 | KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer | ||
NCT03838848 | KN046 in Patients With Advanced Non-small Cell Lung Cancer | ||
NCT03733951 | KN046 in Subjects With Advanced Solid Tumors and Lymphoma | ||
NCT03619681 | Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer | ||
NCT04612712 | A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors | ||
NCT04984668 | A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors | ||
NCT04925947 | A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors | ||
NCT04040699 | KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor |